Biocon's pre-tax profit rises 9% to Rs 315 crore in Oct-Dec quarter | Business Standard News
Biocon Biologics enters licensing agreement with Yoshindo of Japan - The Hindu BusinessLine
Meet Biocon Biologics: A 2021 Facility of the Year Honorable Mention Award Winner | Pharmaceutical Engineering
Research Centre - Biocon
BIOCON Stock Price and Chart — NSE:BIOCON — TradingView
Biocon Academy - Biocon
Manufacturing Operations - Biocon - Global Biopharmaceutical company
Fortune India: Business News, Strategy, Finance and Corporate Insight
Biocon Biologics to Acquire Viatris' Biosimilars Assets for up to USD 3.335 billion in Stock and Cash
Biocon Campus - Biocon
Biocon Biologics' antibody drug unit in Bengaluru gets EU GMP certificate | Business Standard News
Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
India's Biocon Biologics to receive $150m from Goldman Sachs - Nikkei Asia
Biocon Biologics Receives USD 150 Million Capital Injection from Goldman Sachs - Biocon
Biocon Biologics (@BioconBiologics) / Twitter
Covid has created an 'ecosystem' of innovation in India, says Biocon chief Kiran Mazumdar-Shaw | Mint
Research Centre - Biocon
Biocon Biologics appoints Susheel Umesh as Chief Commercial Officer for emerging markets | Deccan Herald
Joint drugs controller nabbed taking bribe to clear Biocon Biologics's diabetes injection | Mint
Biocon in pact with Japan's Yoshindo to commercialise two biosimilar assets | Mint
Biocon logo in transparent PNG format
Syngene International: Biocon sells 5.4% stake in arm Syngene International - The Economic Times
